劉雪松    助理教授、研究員
所在學院生命科學與技術學院
研究方向癌癥生物學
聯系方式liuxs@shanghaitech.edu.cn


個人簡介
2002年本科畢業于武漢大學生命科學學院。
2007年在中科院上海生命科學研究院健康科學研究所獲博士學位。
2008年至2015年在美國哈佛大學醫學院以及公共衛生學院從事博士后研究工作。
2015年6月加入上??萍即髮W生命科學與技術學院任助理教授、研究員。


主要研究內容
實驗室主要研究方向是腫瘤分子遺傳和免疫基因組學。研究內容包括:1,腫瘤分子遺傳,結合小鼠模型,生化細胞手段研究腫瘤新靶標和機制。研究新腫瘤特異基因、新腫瘤DNA變異的功能;制備新式腫瘤小鼠模型,精確模擬由體細胞多基因突變引發的人類腫瘤。2,腫瘤免疫基因組,從腫瘤基因組角度研究免疫治療的標志物和靶標。發現新的腫瘤基因組標志物以高效區分免疫治療有反應和不反應病人;提高腫瘤細胞免疫原性,把免疫治療不反應病人變成有反應病人。研究手段有:腫瘤基因組生物信息學分析、生化細胞技術和小鼠模型。詳情可參考實驗室主頁:http://liuxslab.www.istanaradio.com

代表性論文

# First author; * Corresponding author.

22. Wang S (#), Cowley LA (#), Liu XS (*). Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and     Therapeutic Strategy. Molecules 2019, 24, 3214.

21. Wang S, Liu XS. The UCSCXenaTools R package: a toolkit for accessing genomics data from UCSC Xena       platform, from cancer multi-omics to single-cell RNA-seq. Journal of Open Source Software, 4(40), 1627, (2019).

20. He Z (#), Wang S (#), Shao Y (#), Zhang J (#), Wu X, Chen Y, Hu J, Zhang F, Liu XS (*). Ras downstream effector GGCT alleviates oncogenic stress. iScience 2019 Jul 26;19:256-266.

19. Wang S (#), Zhang J, He Z, Wu K, Liu XS (*). The predictive power of tumor mutational burden in lung cancer    immunotherapy response is influenced by patients' sex. Int J Cancer. 2019 Apr 10. doi: 10.1002/ijc.32327.

18. Wang SX (#), Jia MM (#), He ZK, Liu XS (*). APOBEC3B and APOBEC mutational signature as potential          predictive markers for immunotherapy response in non-small cell lung cancer. Oncogene.                                          2018 Jul;37(29):3924-3936.

17. Gerarduzzi C (#), de Polo A, Liu XS, El Kharbili M, Little JB, Yuan ZM (*). Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE. J Biol Chem. 2016 Dec 9;291(50):25937-25949.

16. Chen M (#), Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J,   Katon JM, Menon AV, Webster KA, Ng C, Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J,               Signoretti S, Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP (*). An aberrant        SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nat Genet. 2018 Feb;50(2):206-218.

15. Liu XS (#), Liu Z, Gerarduzzi C, Choi DE, Ganapathy S, Pandolfi PP, Yuan ZM (*). Somatic human ZBTB7A      zinc finger mutations promote cancer progression. Oncogene. 2016 Jun 9;35(23):3071-8.                                         doi: 10.1038/onc.2015.371.

14. Liu XS (#), Chandramouly G, Rass E, Guan Y, Wang G, Hobbs RM, Rajendran A, Xie A, Shah JV, Davis AJ,    Scully R (*), Lunardi A (#, *), Pandolfi PP (*). LRF maintains genome integrity by regulating the non-homologous     end joining pathway of DNA repair. Nature Communications. 2015 Oct 8; 6:8325. doi: 10.1038/ncomms9325.

13. Liu XS (#), Genet MD, Haines JE, Mehanna EK, Wu S, Chen HI, Chen Y, Qureshi AA, Han J, Chen X,    Fisher DE, Pandolfi PP, Yuan ZM (*). ZBTB7A suppresses melanoma metastasis by transcriptionally repressing MCAM.   Mol Cancer Res. 2015, 13(8):1206-17.

12. Liu XS (#), Little JB, Yuan ZM (*). Glycolytic metabolism influences global chromatin structure. Oncotarget.       2015, 6(6):4214-25.

11. Liu XS (#), Haines JE, Mehanna EK, Genet MD, Ben-Sahra I, Asara JM, Manning BD, Yuan ZM (*). ZBTB7A    acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes Dev. 2014, 28(17):1917-28. (Highlighted in Nature Reviews Cancer: Isabel Lokody, Nature Reviews Cancer, 14, 649 (2014)) 

10. González-Billalabeitia E (#), Seitzer N (#), Song SJ, Song MS, Patnaik A, Liu XS, Epping MT, Papa A, Hobbs   RM, Chen M, Lunardi A, Ng C, Webster KA, Signoretti S, Loda M, Asara JM, Nardella C, Clohessy JG, Cantley LC, Pandolfi PP (*). Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.           Cancer Discov. 2014, 4(8):896-904.

9. Wang G (#), Lunardi A (#), Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP (*).      Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence         bypass and tumor invasion. Nat Genet. 2013, 45(7):739-46.

8. Zhang HX (#), Liu ZX (#), Sun YP (#), Zhu J, Lu SY, Liu XS, Huang QH, Xie YY, Zhu HB, Dang SY, Chen HF,      Zheng GY, Li YX, Kuang Y, Fei J, Chen SJ, Chen Z (*), Wang ZG (*). Rig-I regulates NF-κB activity through binding  to Nf-κb1 3'-UTR mRNA. Proc Natl Acad Sci U S A. 2013, 110(16):6459-64.

7. Liu XS (#), Zhao XD (#), Wang X (#), Yao YX, Zhang LL, Shu RZ, Ren WH, Huang Y, Huang L, Gu MM, Kuang Y, Wang L, Lu SY, Chi J, Fen JS, Wang YF, Fei J, Dai W (*), Wang ZG (*). Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E. Genes Cancer.                2010, 1(1):26-39. (* co-first author) (Highlighted as cover story)

6. Shu RZ (#), Zhang F, Liu XS, Li CL, Wang L, Tai YL, Wu XL, Yang X, Liao XD, Jin Y, Gu MM, Huang L, Pang XF, Wang ZG (*). Target deletion of the cytoskeleton-associated protein palladin does not impair neurite outgrowth in mice. PLoS One. 2009, 4(9):e6916.

5. Wu XL (#), Gu MM (#), Huang L, Liu XS, Zhang HX, Ding XY, Xu JQ, Cui B, Wang L, Lu SY, Chen XY, Zhang     HG, Huang W, Yuan WT, Yang JM, Gu Q, Fei J, Chen Z, Yuan ZM, Wang ZG (*). Multiple synostoses syndrome is  due to a missense mutation in exon 2 of FGF9 gene. Am J Hum Genet. 2009, 85(1):53-63.

4. Wang Y (#), Zhang HX, Sun YP, Liu ZX, Liu XS, Wang L, Lu SY, Kong H, Liu QL, Li XH, Lu ZY, Chen SJ, Chen Z, Bao SS, Dai W, Wang ZG (*). Rig-I-/- mice develop colitis associated with downregulation of G alpha i2. Cell Res.   2007, 17(10):858-68.

3. Liu XS (#), Li XH, Wang Y, Shu RZ, Wang L, Lu SY, Kong H, Jin YE, Zhang LJ, Fei J, Chen SJ, Chen Z, Gu MM, Lu ZY, Wang ZG (*). Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblas-tic island formation in mouse fetal liver. Blood. 2007, 110(3):870-76.

2. Liu XS (#), Luo HJ, Yang H, Wang L, Kong H, Jin YE, Wang F, Gu MM, Chen Z, Lu ZY, Wang ZG (*). Palladin      regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and     stabilizing beta1-integrin. J Cell Biochem. 2007, 100(5):1288-300.

1. Luo H (#), Liu X (#), Wang F, Huang Q, Shen S, Wang L, Xu G, Sun X, Kong H, Gu M, Chen S, Chen Z,             Wang Z (*). Disruption of palladin results in neural tube closure defects in mice. Mol Cell Neurosci.                          2005, 29(4):507-15. 



瀏覽次數:17265

返回原圖
/

 

湖南幸运赛车开奖直播